Product Pipeline

 

Innovative, exciting technology with extraordinary potential

Our pipeline currently centers on two promising compounds developed by world renowned Professors’ Chang and Han.

This platform drug as shown promise for the treatment of Acute Myeloid Leukemia.  Formally known as TPA, this platform small molecule has many potential therapeutic uses.  Rich Pharmaceuticals is exploring multiple indications for the highest likelihood of commercialization success that has the potential to become new compelling treatments for patients.

pipeline

News

March 21st, 2017

Rich Pharmaceuticals To Launch CannCodex, marking its entry into Medicinal Cannabis Industry
View Release

February 28th, 2017

Rich Pharmaceuticals Attracts New Financing Package with GHS Investments, LLC
View Release

September 27th, 2016

Rich Pharmaceuticals, Inc. Announces Quarterly Milestones
View Release

» View All News

Stock Price